These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Lipoprotein (a) as a risk factor in the development of atherosclerosis]. Liakishev AA; Pokrovskiĭ SN; Susekov AV Kardiologiia; 1991 Feb; 31(2):71-5. PubMed ID: 1828281 [No Abstract] [Full Text] [Related]
3. [Treatment of hyperlipidemia in diabetes mellitus]. Onuma T; Kawamori R Nihon Rinsho; 2001 Mar; 59 Suppl 3():143-51. PubMed ID: 11347047 [No Abstract] [Full Text] [Related]
4. [Disorders of lipoprotein metabolism as a risk factor in atherosclerosis in patients with glomerulonephritis]. Nikulina GG; Petrun' NM; Mel'man NIa; Zel'dich IM; Serbina IE Vrach Delo; 1983 Aug; (8):53-6. PubMed ID: 6636687 [No Abstract] [Full Text] [Related]
5. A comparative study of the effect of dietary cholesterol on plasma lipoproteins in nonhuman primates. Paula RK; Rudel LL; Clarkson TB Adv Exp Med Biol; 1977; 82():256-8. PubMed ID: 200093 [No Abstract] [Full Text] [Related]
6. [Metabolism and clinical significance of lipoprotein Lp(a) (author's transl)]. Krempler F Acta Med Austriaca; 1980; 7(4-5):101-3. PubMed ID: 6454320 [TBL] [Abstract][Full Text] [Related]
7. Atherogenicity of triglyceride-rich lipoproteins. Krauss RM Am J Cardiol; 1998 Feb; 81(4A):13B-17B. PubMed ID: 9526808 [TBL] [Abstract][Full Text] [Related]
8. Older plasma lipoproteins are more susceptible to oxidation: a linking mechanism for the lipid and oxidation theories of atherosclerotic cardiovascular disease. Walzem RL; Watkins S; Frankel EN; Hansen RJ; German JB Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7460-4. PubMed ID: 7638213 [TBL] [Abstract][Full Text] [Related]
10. Lipoprotein abnormalities in hypertriglyceridemia: significance in atherosclerosis. Eisenberg S Am Heart J; 1987 Feb; 113(2 Pt 2):555-61. PubMed ID: 3544770 [No Abstract] [Full Text] [Related]
11. [Lipoprotein (a)]. Airoldi G; Campanini M; Cusinato S; Monteverde A Ann Ital Med Int; 1990; 5(4 Pt 1):405-12. PubMed ID: 2151206 [TBL] [Abstract][Full Text] [Related]
12. Lipoproteins and the relative importance of plasma cholesterol and triglycerides in peripheral arterial disease. Newall RG; Bliss BP Angiology; 1973 May; 24(5):297-302. PubMed ID: 4350611 [No Abstract] [Full Text] [Related]
13. [Measuring postprandial lipoproteins]. Luley C; Hanisch M; Probst R; Weber P; Schrezenmeir J; Vohwinkel M; Lodde M; Klör HU; Wieland H Klin Wochenschr; 1990; 68 Suppl 22():46-53. PubMed ID: 2087079 [No Abstract] [Full Text] [Related]
14. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Skålén K; Gustafsson M; Rydberg EK; Hultén LM; Wiklund O; Innerarity TL; Borén J Nature; 2002 Jun; 417(6890):750-4. PubMed ID: 12066187 [TBL] [Abstract][Full Text] [Related]
15. On the relation between peripheral atherosclerosis and serum lipoproteins. Erikson U; Ericsson M; Persson R Ups J Med Sci; 1979; 84(1):95-104. PubMed ID: 220766 [TBL] [Abstract][Full Text] [Related]
16. Triglycerides and atherogenic lipoproteins: rationale for lipid management. Krauss RM Am J Med; 1998 Jul; 105(1A):58S-62S. PubMed ID: 9707269 [TBL] [Abstract][Full Text] [Related]
17. [Progress in the study of lipoprotein metabolism and atherosclerosis: role of blood lipoproteins and pathogenesis of atherosclerosis]. Kawamura M; Naito C Nihon Rinsho; 1988 Mar; 46(3):621-8. PubMed ID: 3404688 [No Abstract] [Full Text] [Related]
18. Atherogenic lipoprotein profile in families with and without history of early myocardial infarction. Dobiásová M; Raslová K; Rauchová H; Vohnout B; Ptácková K; Frohlich J Physiol Res; 2001; 50(1):1-8. PubMed ID: 11300220 [TBL] [Abstract][Full Text] [Related]
19. Lipoproteins: what, when, and how often to measure. Brown WV Heart Dis Stroke; 1992; 1(1):20-6. PubMed ID: 1344644 [No Abstract] [Full Text] [Related]
20. Role of triglyceride-rich lipoproteins in atherogenesis. Zilversmit DB Ann N Y Acad Sci; 1976; 275():138-44. PubMed ID: 188364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]